Caliway Biopharmaceuticals Co., Ltd.
6919Biotechnology
NT$65.40−3.11%As of Oct 29vs prior close
- Market cap
- $3.1B
- P/E (TTM)
- –
- P/E (FY1)
- 35.0×
- From 52W high
- −64.26%
- EPS (TTM)
- -NT$0.17
- Revenue (TTM)
- NT$29.4M
- Net margin
- -877.11%
Nomior Score
34
Steady ProfileBottom 20% of the scored universe
Growth—
Quality51
Value53
Momentum12
Resilience42